The unified social credit code/registration number of Tianjin Xiangmin Pharmaceutical Co., Ltd. is 91120223671459146 E, and the enterprise is in the opening state.
The business scope of Tianjin Xiangmin Pharmaceutical Co., Ltd. is: drug production; Raw material production (amantadine hydrochloride, telmisartan); Manufacturing, processing and sales of pharmaceutical intermediates (except dangerous goods and easy-to-make drugs); 1- bromoadamantane (containing 32.8% adamantane, 59% bromine and 8.2% sodium metabisulfite), adamantane (containing 58.3% tetrahydrodicyclopentadiene and 4 1.7% aluminum trichloride), 1- amantadine (containing 48.3% tetrahydrodicyclopentadiene) Development, consultation and transfer of medical technology; Import and export of goods and technologies (except those restricted by laws and regulations); Ordinary freight. (Projects subject to approval according to law can only be operated after approval by relevant departments). In Tianjin, the total registered capital of companies with similar business scope is 55210.7 million yuan, and the main capital is concentrated in seven enterprises with a scale of more than 50 million. In the province, the registered capital of enterprises is good at present.
See more information and materials of Tianjin Xiangmin Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.